Besides possible direct interactions between AR and GR signals indicated in prostate cancer [83], NF-κB is known to inhibit GR activity via down-regulating the expression of target genes that are normally up-regulated by NF-κB [45]. The gene discussed is NR3C1; the disease is prostate carcinoma.